PTH and chronic kidney disease: Despite the availability of various treatments, the management of SHPT represents an unmet medical need; in fact, SHPT remains uncontrolled in many CKD patients, and only 15–20% of them simultaneously reach the target levels of PTH, calcium, and phosphorus [14,15,16].